BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9156353)

  • 1. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.
    Li Q; Zhang L; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1995 Dec; 116(7):2963-70. PubMed ID: 8680731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q; Zhang J; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1996 Aug; 118(7):1653-8. PubMed ID: 8842428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.
    Hawcock AB; Barnes JC; Michel AD
    Br J Pharmacol; 1992 Mar; 105(3):686-90. PubMed ID: 1628155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
    Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
    Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Peral de Bruno M; Coviello A
    J Comp Physiol B; 1996; 165(7):565-70. PubMed ID: 8617893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
    Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
    Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.
    Hawcock AB; Barnes JC
    Br J Pharmacol; 1993 Apr; 108(4):1150-5. PubMed ID: 8485624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of contractile response to angiotensin in epididymal rat vas deferens.
    Sum CS; Cheung WT
    Pharmacology; 1995 Aug; 51(2):105-11. PubMed ID: 8584570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
    Abdelrahman A; Pang CC
    Can J Physiol Pharmacol; 1992 May; 70(5):716-9. PubMed ID: 1423014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
    Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
    Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
    Tripodi F; Stanke-Labesque F; Devillier P; Chavanon O; Sessa C; Bessard G
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):734-40. PubMed ID: 10547091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
    Yang Z; Arnet U; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S17-22. PubMed ID: 7508047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel angiotensin receptor subtypes in fowl.
    Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of angiotensin peptides in the regulation of clitoral cavernosum smooth muscle tone.
    Park JK; Kim SZ; Kim JU; Kim YG; Kim SM; Cho KW
    Int J Impot Res; 2002 Apr; 14(2):72-80. PubMed ID: 11979320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.